A detailed history of Pds Planning, Inc transactions in Pfizer Inc stock. As of the latest transaction made, Pds Planning, Inc holds 31,446 shares of PFE stock, worth $825,143. This represents 0.08% of its overall portfolio holdings.

Number of Shares
31,446
Previous 28,209 11.48%
Holding current value
$825,143
Previous $789,000 15.34%
% of portfolio
0.08%
Previous 0.08%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 29, 2024

BUY
$27.7 - $31.39 $89,664 - $101,609
3,237 Added 11.48%
31,446 $910,000
Q2 2024

Aug 07, 2024

BUY
$25.26 - $29.6 $96,089 - $112,598
3,804 Added 15.59%
28,209 $789,000
Q1 2024

May 01, 2024

SELL
$25.89 - $29.73 $31,145 - $35,765
-1,203 Reduced 4.7%
24,405 $677,000
Q4 2023

Feb 01, 2024

BUY
$26.13 - $33.94 $25,293 - $32,853
968 Added 3.93%
25,608 $737,000
Q3 2023

Oct 20, 2023

SELL
$32.09 - $37.51 $89,306 - $104,390
-2,783 Reduced 10.15%
24,640 $817,000
Q2 2023

Jul 20, 2023

SELL
$36.12 - $41.79 $33,736 - $39,031
-934 Reduced 3.29%
27,423 $1.01 Million
Q1 2023

May 01, 2023

BUY
$39.39 - $51.28 $360,536 - $469,365
9,153 Added 47.66%
28,357 $1.16 Million
Q4 2022

Jan 26, 2023

BUY
$41.75 - $54.5 $24,465 - $31,937
586 Added 3.15%
19,204 $0
Q3 2022

Nov 02, 2022

SELL
$43.76 - $53.42 $17,197 - $20,994
-393 Reduced 2.07%
18,618 $815,000
Q2 2022

Jul 15, 2022

BUY
$46.53 - $55.17 $930 - $1,103
20 Added 0.11%
19,011 $997,000
Q1 2022

Apr 18, 2022

BUY
$45.75 - $56.69 $223,626 - $277,100
4,888 Added 34.66%
18,991 $983,000
Q4 2021

Jan 25, 2022

SELL
$41.32 - $61.25 $185,485 - $274,951
-4,489 Reduced 24.14%
14,103 $833,000
Q3 2021

Oct 22, 2021

BUY
$39.25 - $50.42 $17,858 - $22,941
455 Added 2.51%
18,592 $800,000
Q2 2021

Jul 26, 2021

BUY
$35.91 - $40.68 $51,638 - $58,497
1,438 Added 8.61%
18,137 $710,000
Q1 2021

Apr 20, 2021

BUY
$33.49 - $37.77 $4,454 - $5,023
133 Added 0.8%
16,699 $605,000
Q4 2020

Jan 21, 2021

BUY
$33.47 - $42.56 $55,995 - $71,202
1,673 Added 11.23%
16,566 $610,000
Q3 2020

Oct 19, 2020

BUY
$31.75 - $37.25 $36,449 - $42,763
1,148 Added 8.35%
14,893 $547,000
Q2 2020

Aug 11, 2020

BUY
$30.12 - $36.54 $33,794 - $40,997
1,122 Added 8.89%
13,745 $449,000
Q1 2020

Apr 20, 2020

SELL
$27.03 - $38.62 $21,272 - $30,393
-787 Reduced 5.87%
12,623 $412,000
Q4 2019

Feb 07, 2020

BUY
$32.92 - $37.36 $37,100 - $42,104
1,127 Added 9.18%
13,410 $525,000
Q3 2019

Oct 28, 2019

BUY
$32.49 - $42.13 $106,794 - $138,481
3,287 Added 36.54%
12,283 $441,000
Q2 2019

Aug 14, 2019

BUY
$36.98 - $41.52 $7,137 - $8,013
193 Added 2.19%
8,996 $390,000
Q1 2019

Apr 19, 2019

BUY
$37.5 - $41.2 $13,875 - $15,244
370 Added 4.39%
8,803 $374,000
Q4 2018

Feb 08, 2019

BUY
$38.47 - $43.86 $9,886 - $11,272
257 Added 3.14%
8,433 $368,000
Q3 2018

Nov 02, 2018

BUY
$34.47 - $41.81 $61,839 - $75,007
1,794 Added 28.11%
8,176 $360,000
Q2 2018

Jul 27, 2018

BUY
$32.98 - $35.16 $197 - $210
6 Added 0.09%
6,382 $232,000
Q1 2018

May 03, 2018

SELL
$31.91 - $37.02 $1,372 - $1,591
-43 Reduced 0.67%
6,376 $226,000
Q4 2017

Feb 14, 2018

BUY
$33.26 - $35.29 $213,495 - $226,526
6,419
6,419 $232,000

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $147B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Pds Planning, Inc Portfolio

Follow Pds Planning, Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pds Planning, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Pds Planning, Inc with notifications on news.